9 Results for "

drug-drug interactions

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "drug-drug interactions" in MCE Product Catalog:

Cat. No.: HY-168046
CAS No.: 2542029-03-6
Research Areas:  

Metabolic Disease

ALG-055009 is a selective and orally active Thyroid Hormone Receptor Beta (THR-β) agonist with an EC50 of 0.063 μM. ALG-055009 binds to the T3 hormone pocket of human THR-β, forming polar interactions with protein residues. ALG-055009 can lower total cholesterol levels in rats on a high-fat diet. ALG-055009 exhibits high metabolic stability, good permeability, a long in vivo half-life, and limited drug-drug interaction liability. ALG-055009 can be used in studies related to metabolic dysfunction-associated fatty liver disease .
loading...
    loading...
Cat. No.: HY-176515
CAS No.: 3118400-26-0
Synonyms: Ciprofol Glucuronide
Target:  

Drug Metabolite

Research Areas:  

Neurological Disease

Cipepofol glucuronide (Ciprofol Glucuronide) (M4) is a glucuronide metabolite of Ciprofol (HY-116152). Cipepofol glucuronide has no significant inhibitory activity toward P450s and UDP-glucuronosyltransferases (UGTs), and it has a lower risk of acting as a perpetrator for drug-drug interactions (DDIs). Cipepofol glucuronide can be used for anesthesia research .
loading...
    loading...
Cat. No.: HY-W064918
CAS No.: 1473450-60-0
Target:  

Bacterial

Research Areas:  

Infection

NITD-304 is an orally active anti-tuberculosis agent. NITD-304 exerts inhibitory and bactericidal activities gainst Mycobacterium tuberculosis and multidrug-resistant Mycobacterium tuberculosis. NITD-304 inhibits mycobacterial cell wall biosynthesis and demonstrates synergistic or additive growth inhibitory activity with select antibacterial agents. NITD-304 shows low risk of cardiotoxicity and drug-drug interactions, with no inhibition of major cytochrome P-450 enzymes or hERG channel. NITD-304 can be used for the research of tuberculosis and multidrug-resistant tuberculosis .
loading...
    loading...
Cat. No.: HY-172811
CAS No.: 2969158-02-7
Research Areas:  

Metabolic Disease

DA-302168S is an orally active and selective agonist targeting the GLP-1R, with EC50 value of 1.32 nM. DA-302168S reduces blood glucose levels and suppresses appetite, demonstrates minimal safety risks including low hERG channel inhibition and no significant off-target toxicity, and mitigates drug-drug interaction risk. DA-302168S can be used for the research of type 2 diabetes and obesity .
loading...
    loading...
Cat. No.: HY-169320
CAS No.: 2998548-72-2
Research Areas:  

Cancer

SJPYT-328 is a PXR agonsit. PXR plays a major role in drug metabolism and drug-drug interactions .
loading...
    loading...
Cat. No.: HY-D2921
CAS No.: 1622162-61-1
BODIPY-FL-Vindoline is a high-affinity fluorescent probe for the pregnane X receptor (PXR), with a Kd of 256 nM. BODIPY-FL-Vindoline can be used in the research of drug metabolism and drug-drug interactions .
loading...
    loading...
Cat. No.: HY-172808
CAS No.: 2836313-12-1
Research Areas:  

Metabolic Disease

BNS808 is an orally active and selective cannabinoid-1 receptor (CB1R) antagonist (IC50 = 0.8 nM) with notable CB2R selectivity and minimal brain penetration. BNS808 is studied in research on obesity and its associated metabolic complications, such as metabolic dysfunctional-associated steatotic liver disease (MASLD). BNS808 has reduced free drug availability for CNS entry, enhancing safety and minimizing drug-drug interactions through high plasma binding .
loading...
    loading...
Cat. No.: HY-181151
CAS No.: 2457357-91-2
Target:  

Monoamine Transporter

Research Areas:  

Neurological Disease

DLX48 is a LeuBAT (Δ13 mutant) transporter inhibitor that binds to the transporter’s active site. DLX48 can crosses the blood-brain barrier, and has a lower risk of cytochrome P450-related drug-drug interactions. DLX48 can be used for the research of major depressive disorder .
loading...
    loading...
Cat. No.: HY-D3433
CAS No.: 222159-75-3
Synonyms: CDCSF
Target:  

Fluorescent Dye

Research Areas:  

Others

5-Carboxy-2′,7′-dichlorosulfonefluorescein (CDCSF) is a fluorescein derivative-based fluorescent probe. 5-Carboxy-2′,7′-dichlorosulfonefluorescein serves as a fluorescent substrate for the organic anion transporting polypeptide OATP2B1, and is specifically recognized and transported into cells by OATP2B1 under acidic pH conditions, making it suitable for in vitro high-throughput screening of drug-drug interactions (DDI) and food-drug interactions (FDI) (Ex/Em = 485/535 nm) .
loading...
    loading...